Literature DB >> 26676682

Serum marker %[-2]proPSA and the Prostate Health Index improve diagnostic accuracy for clinically relevant prostate cancer.

Robert W Veltri1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26676682     DOI： 10.1111/bju.13151

Source DB:  PubMed          Journal:  BJU Int        ISSN： 1464-4096            Impact factor:   5.588


× No keyword cloud information.
  2 in total

1.  Risk assessment models to evaluate the necessity of prostate biopsies in North Chinese patients with 4-50 ng/mL PSA.

Authors:  Jing Zhao; Shuai Liu; Dexuan Gao; Sentai Ding; Zhihong Niu; Hui Zhang; Zhilong Huang; Juhui Qiu; Qing Li; Ning Li; Fang Xie; Jilei Cui; Jiaju Lu
Journal:  Oncotarget       Date:  2017-02-07

2.  Computer Extracted Features from Initial H&E Tissue Biopsies Predict Disease Progression for Prostate Cancer Patients on Active Surveillance.

Authors:  Sacheth Chandramouli; Patrick Leo; George Lee; Robin Elliott; Christine Davis; Guangjing Zhu; Pingfu Fu; Jonathan I Epstein; Robert Veltri; Anant Madabhushi
Journal:  Cancers (Basel)       Date:  2020-09-21       Impact factor: 6.639
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.